1. Home
  2. BLIN vs LYRA Comparison

BLIN vs LYRA Comparison

Compare BLIN & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLIN
  • LYRA
  • Stock Information
  • Founded
  • BLIN 2000
  • LYRA 2005
  • Country
  • BLIN United States
  • LYRA United States
  • Employees
  • BLIN N/A
  • LYRA 30
  • Industry
  • BLIN EDP Services
  • LYRA Medical/Dental Instruments
  • Sector
  • BLIN Technology
  • LYRA Health Care
  • Exchange
  • BLIN Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • BLIN 16.5M
  • LYRA 15.0M
  • IPO Year
  • BLIN 2007
  • LYRA 2020
  • Fundamental
  • Price
  • BLIN $1.41
  • LYRA $10.61
  • Analyst Decision
  • BLIN Strong Buy
  • LYRA Buy
  • Analyst Count
  • BLIN 1
  • LYRA 2
  • Target Price
  • BLIN $4.62
  • LYRA $16.00
  • AVG Volume (30 Days)
  • BLIN 31.4K
  • LYRA 1.9M
  • Earning Date
  • BLIN 08-13-2025
  • LYRA 08-13-2025
  • Dividend Yield
  • BLIN N/A
  • LYRA N/A
  • EPS Growth
  • BLIN N/A
  • LYRA N/A
  • EPS
  • BLIN N/A
  • LYRA N/A
  • Revenue
  • BLIN $15,465,000.00
  • LYRA $1,185,000.00
  • Revenue This Year
  • BLIN $4.08
  • LYRA N/A
  • Revenue Next Year
  • BLIN $12.95
  • LYRA $1,286.17
  • P/E Ratio
  • BLIN N/A
  • LYRA N/A
  • Revenue Growth
  • BLIN 1.30
  • LYRA N/A
  • 52 Week Low
  • BLIN $0.76
  • LYRA $3.81
  • 52 Week High
  • BLIN $2.80
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • BLIN 31.33
  • LYRA 47.78
  • Support Level
  • BLIN $1.49
  • LYRA $9.81
  • Resistance Level
  • BLIN $1.62
  • LYRA $11.13
  • Average True Range (ATR)
  • BLIN 0.06
  • LYRA 3.17
  • MACD
  • BLIN -0.01
  • LYRA -1.04
  • Stochastic Oscillator
  • BLIN 0.00
  • LYRA 3.31

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: